Acacia Product Scoping Session response..

[Warwick LAngebrink]

Afternoon everyone,

 

Attached please what we hope to be minutes and a comprehensive response to matters raised in the product scoping session incl:

·         Opinions and tax analysis incl legal, bankruptcy remoteness, regulatory compliance, operation of security arrangements, uncompropisable flow of funds.

·         Certificates:  NCD and ABSA Pledge Certs

·         Credit Rating AA+ for Stanlib

·         Pricing methodology (amplified in muinutes and pricing annexure also attached)

 

CONFIDENTIALITY:

Please note that we would feel very uncomfortable if all of this information was made available to anyone outside of the Product Scoping meeting, because we have gone to extraordinary lengthes to give you detailed insight into the depths of our operations.  Confidentiality to be preserved please.

 

Please also note the following health warning on the Advocate Farlam opinion:   “NB:  This opinion contains EXTRACTS from the original Advocate Farlam Opinion, and paragraphs from the original opinion relating to specific legs of the Stanlib transaction that are not relevant to the Analytics transaction (e.g. secondary pledges with reversionary rights) have been OMITTED.  The following PDF is therefore NOT a complete opinion and was NOT specifically procured for the Analytics transaction.  We are briefing Adv Farlam again on Wednesday 5 November, and we are reasonably certain, confident  that he will reach the same (or substantially similar) conclusions with regard to bankruptcy remoteness, regulatory compliance, operation of security arrangements,  and that his legal opinion on efficacy of the legal safeguards implemented to ensure that the flow of funds to Investor will not be interrupted of diluted in any way will remain positive.

 

Enjoy your weekend!!

 

Kind regards

Warwick Langebrink

+27 11 268 0530      (SA)

+27 82 610 0444       (mobile)